12:00 AM
 | 
Jan 07, 2013
 |  BC Week In Review  |  Company News  |  Other News

Eli Lilly pharmaceuticals news

On Dec. 20, 2012, Eli Lilly said it agreed to pay $29.4 million to settle issues regarding compliance with the U.S. Foreign Corrupt Practices Act (FCPA). The settlement relates to an investigation by the SEC of...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >